RT Journal Article
SR Electronic
T1 869 Venetoclax, a specific BCL-2 inhibitor, modulates CAR T cells genetically and functionally during production and augments their anti-tumor response
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A968
OP A968
DO 10.1136/jitc-2023-SITC2023.0869
VO 11
IS Suppl 1
A1 Aboelella, Nada S
A1 Park, Ryan
A1 Pan, Tony
A1 Tang, Erting
A1 Huang, Jun
A1 LaBelle, James
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A968.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.